FDA's New Guidance on Compounding Bulk Drug Substances - Video

In this webinar, Dr. Bailey presents information on the Indexing program and explains the difference between FDA indexed, approved, and conditionally-approved drugs. Dr. McCoig presents information on FDA’s new guidance for compounding from bulk substances, how FDA guidance applies to laboratory animal care and use, and answers questions from the laboratory animal community. Dr. Petervary clarifies OLAW's definition of "non-pharmaceutical grade substances."